In addition to the detection of cIg in the serum of pancreatic cancer patients, it is demonstrated that cIg and its mRNA can be detected locally in pancreatic cancer through immunohistochemistry (IHC), Western blotting, polymerase chain reaction (PCR), and in situ hybridization 46. Here, FN1 is linked to pancreatic neoplasm.